Pancreatic Cancer Research

ResearcherTongji HospitalNo recent work listed

Qianqian Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8454-6187; OpenAlex author ID A5082778481. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers

Papers 5

  1. Structure-based analysis of a natural GOT1-inhibitor Aspulvinone H arrests pancreatic ductal adenocarcinoma cells growth Co-author DOI 10.22541/au.161881470.02929068/v1↗
  2. Discovery of GOT1 Inhibitors from a Marine-Derived Aspergillus terreus That Act against Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/md19110588↗
  3. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer. Co-author DOI 10.1002/1878-0261.12443↗
  4. ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway. First author DOI 10.1002/jcb.27155↗
  5. Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells. Co-author DOI 10.1016/j.gene.2015.12.039↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiguang Sun · 2 shared papers, 2021 · strength 0.31
  2. Changxing Qi · 2 shared papers, 2021 · strength 0.31
  3. Shan Yan · 2 shared papers, 2021 · strength 0.31
  4. Yonghui Zhang · 2 shared papers, 2021 · strength 0.31
  5. Ming Xiang · 2 shared papers, 2016–2019 · strength 0.16
  6. Jun Liu · 1 shared paper, 2018 · strength 0.11
  7. Jianguo Zhao · 1 shared paper, 2018 · strength 0.11
  8. Fei Han · 1 shared paper, 2018 · strength 0.11
  9. Senlin Li · 1 shared paper, 2019 · strength 0.09
  10. Zhongshi Zhou · 1 shared paper, 2019 · strength 0.09
  11. Rongrong Huang · 1 shared paper, 2019 · strength 0.09
  12. Xiulan Liu · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.